Some Important Information On The Covid Booster

On Thursday, Dr. Marty Makary and Tracy Beth Hoeg wrote an article for The New York Post about the new Covid booster. Dr. Makary is a health care expert at Johns Hopkins University.

The article reports:

Pfizer’s version, approved this week as well, also has zero efficacy data and has not been tested on humans at all. We only have data about antibody production from 10 mice.

The FDA, or Moderna (frankly, it’s hard to tell the difference sometimes), should disclose what happened to the patient who took the new vaccine and had a complication that required medical attention.

The public has a right to know.

The last time the Biden administration approved and recommended a novel COVID bivalent booster, last fall, with no human-outcomes data, it was an epic fail.

Only 17% of Americans took it (and some of those were forced to do so by their employer or school).

Not foreseeing such weak public support for the booster last year, the Biden administration had prepaid pharma $4.9 billion for 171 million doses — many of which were tossed in the wastebasket.

Now it is making the same mistake.

Two weeks ago, the Biden administration upped its orders for the pediatric version of the new COVID vaccines from 14.5 million doses at $1.3 billion to 20 million doses for $1.7 billion, which is more than four times as many pediatric doses as were used last year.

There clearly seems to be a special push this time to give it to children — the same group European regulators are not supporting.

In fact, the original Moderna vaccine was banned in parts of Europe for people under age 30.

European doctors are not alone.

Dr. Paul Offit, a vaccine-mandate supporter and FDA adviser from the University of Pennsylvania, told The Atlantic this week that he’s not going to take the new COVID vaccine.

He didn’t take the bivalent booster last fall either, despite being 72 years old.

While he disagreed with Jha on the booster, he recently confessed, “Yes, he was wrong, but you know you can’t say that exactly.”

Yes, you can.

The article also notes:

Unlike influenza, COVID-19 is constantly circulating, so there is ample opportunity to run a trial; indeed, Moderna already ran a randomized trial.

Its trial of just 50 people began four months ago and oddly only reported 14-day side effects.

Why didn’t it enroll more people in its trial? Why didn’t it report three-month effectiveness and do a proper trial?

Conducting a placebo-controlled trial in people during this time would not only yield useful information; it would enable further study of those subjects three and six months from now, when a winter surge may occur.

Let’s be honest: Follow-up studies of COVID vaccines in general have revealed a disappointing truth — mild efficacy against infection is transient, lasting just a few months.

Perhaps Pfizer and Moderna knew the FDA regulatory process was greased for them and they didn’t have to.

Please follow the link to read the entire article. Our government is not doing us any favors by encouraging Covid booster shots.

A Constitutional Republic Will Only Stand As Long As Its Citizens And Voters Are Able To Stay Informed

On Tuesday, The Western Journal posted an article about the lack of transparency and misinformation coming out of the Centers for Disease Control and Prevention (CDC) during the past two years or so.

The article notes:

The Centers for Disease Control and Prevention is being called out for not sharing the vast quantities of data it had been gathering during the COVID-19 pandemic.

Some medical experts are speculating that the reason why is the fear the data will be “misinterpreted” and used as justification not to follow the agency’s guidelines regarding vaccination and other matters.

“Tell the truth, present the data,” said Dr. Paul Offit, a vaccine expert and adviser to the Food and Drug Administration, The New York Times reported.

…Kristen Nordlund, a spokeswoman for the CDC, told the news outlet the reason much of the data has been withheld is “because basically, at the end of the day, it’s not yet ready for prime time.”

Bureaucracy is another reason.

The CDC is weighed down by multiple layers of bureaucracy, including a requirement to first run information to be released through the Department Health and Human Services and the White House.

“The CDC is a political organization as much as it is a public health organization,” said Samuel Scarpino, managing director of pathogen surveillance at the Rockefeller Foundation’s Pandemic Prevention Institute, the Times reported.

“The steps that it takes to get something like this [covid data] released are often well outside of the control of many of the scientists that work at the CDC.”

The article concludes:

In an opinion piece in The Wall Street Journal last month, Makary (Dr. Marty Makary, a professor and researcher at the Johns Hopkins University School of Medicine) contended that another topic the CDC has been reluctant to address is natural immunity.

“For most of last year, many of us called for the Centers for Disease Control and Prevention to release its data on reinfection rates, but the agency refused,” he wrote.

“Finally last week, the CDC released data from New York and California, which demonstrated natural immunity was 2.8 times as effective in preventing hospitalization and 3.3 to 4.7 times as effective in preventing Covid infection compared with vaccination,” he continued.

Makary further noted the National Institutes of Health resisted acknowledging natural immunity.

“Because of the NIH’s inaction, my Johns Hopkins colleagues and I conducted the study. We found that among 295 unvaccinated people who previously had Covid, antibodies were present in 99 percent of them up to nearly two years after infection,” he wrote.

Makary argued the failure of the CDC to release the data sooner meant many who had previously recovered from COVID and had better immunity than those were just vaccinated needlessly lost their jobs.

He concluded that they should be hired back.

There was a political agenda here and a monetary agenda here. The CDC is too closely tied financially to the drug companies. There was more money in vaccines than there ever was in ivermectin!